In her latest study, Rachel Perry, PhD, of Yale School of Medicine, reveals one of the clearest mechanisms to date behind a question patients often ask: Why
Seyfried’s metabolic framework for cancer would indicate all cancer can only metabolize glucose. Ongoing studies in human’s right now with Seyfried’s press-pulse protocol on glioblastomas (aggressive standard of care only has a 6 month lifespan, so we will see results fairly quickly).
Seyfried’s metabolic framework for cancer would indicate all cancer can only metabolize glucose. Ongoing studies in human’s right now with Seyfried’s press-pulse protocol on glioblastomas (aggressive standard of care only has a 6 month lifespan, so we will see results fairly quickly).